DOI:
10.1055/s-00023610
Drug Research
LinksClose Window
References
Hermansen K, Kipnes M, Luo E et al.
Sitagliptin Study 035 Group. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
Diabetes Obes Metab 2007;
9: 733-745
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.